Lukas Hainz

A landmark clinical analysis has provided compelling evidence that the future of oncology may be found within the very code that fuels the disease, demonstrating that treatments personalized to a tumor's unique genetic profile can dramatically improve patient outcomes. This pivotal research

The silent pandemic of antibiotic resistance, a threat the World Health Organization has elevated to one of the greatest dangers to modern medicine, has an unexpected and pervasive accomplice in the fields and farms that feed the world. A primary pathway for this threat originates in livestock

The development of new medicines for the most critically ill patients is a path fraught with immense challenges, where promising breakthroughs can be abruptly overshadowed by unforeseen safety concerns. In a significant and unexpected development, London-based biopharmaceutical company Pulmocide

A landmark French study involving over 100,000 adults has brought renewed scrutiny to the grocery aisle, suggesting a significant association between higher dietary exposure to specific food preservatives and a modestly increased incidence of cancer. The research, published in The BMJ , leverages

Congenital heart disease stands as the most common and resource-intensive birth defect in the United States, thrusting thousands of families each year into a world of high-stakes surgeries and lifelong medical care. While the clinical focus has traditionally been on the patient's condition and the

We are joined by biopharma expert Ivan Kairatov to discuss a groundbreaking discovery that redefines our understanding of IDH-mutant glioma, the most common malignant brain tumor in young adults. This conversation explores how this cancer begins not as a visible mass, but as a stealthy infiltration

A significant portion of cancer patients do not respond to immunotherapy because their tumors are immunologically inactive, but a groundbreaking collaborative study from Cornell University researchers has unveiled a remarkable solution using ultrasmall fluorescent silica nanoparticles, known as

The immense human toll of chronic pain, a silent epidemic that shadows the lives of millions, has long been inseparable from the specter of opioid addiction, a devastating crisis born from the very attempt to find relief. For decades, patients and physicians have navigated this perilous landscape,

Pancreatic cancer has long maintained a daunting reputation as one of the most aggressive and difficult-to-treat malignancies, a challenge largely defined by its resistance to standardized therapies and the limitations of conventional research models. For patients and clinicians alike, the path of

With a deep background in biopharma and a keen eye on the intersection of technology and medicine, Ivan Kairatov brings a critical perspective to the evolving landscape of nutritional science. We sat down with him to dissect a recent, comprehensive meta-analysis on the ketogenic diet's role in